Oral care compositions and methods
AssigneeColgate-Palmolive Company
InventorsWei Wang, Virginia Barnes, Harsh M. Trivedi, Tao Xu
Life of this patent
Estimating the term…
Abstract
Described herein are compositions comprising a MMP-13 inhibitor, and methods of using the same.
Claims12
A composition comprising a therapeutically effective amount of a MMP-13 inhibitor, and an orally acceptable carrier, wherein the MMP-13 inhibitor is 4-acetamidophenyl 2-isopropyl-5-methylcyclohexyl carbonate.
A method for treating a condition associated with aberrant MMP-13 expression comprising administering to a subject a therapeutically effective amount of acetyl keto β-bosweilic acid, wherein the acetyl ketop-boswellic acid is administered in the form of a dentifrice composition.
A method for treating a condition associated with aberrant MMP-13 expression comprising administering to a subject to therapeutically effective amount of 2-isopropyl-5-methylcyclohexyl2-hydroxy phenylcarbamate, wherein the condition associated with aberrant MMP-13 expression is selected from the group consisting of degradation of the extracellular matrix, loss of attachment one or more teeth, tooth loss, tooth mobility, pocket formation, and combinations of two or more thereof, and wherein the 2-isopropyl-5-methylcyclohexyl 2-hydroxyphenylcarbamate is administered in the form of a dentifrice composition.
Dependencies are inferred from the claim text.